Latest Breaking News On - Regeneron pharmaceuticals stock down - Page 4 : comparemela.com

Fmr LLC increased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 9,840,892 shares of the biopharmaceutical company’s stock after buying an additional 669,517 shares during the period. Regeneron Pharmaceuticals accounts […]

Bonniel basslerArthurf ryanRaymond jamesRegeneron pharmaceuticals incRegeneron pharmaceuticals stock downMilestone investment advisorsSecurities exchange commissionAnnis gardner whiting capital advisorsInsider transactions at regeneron pharmaceuticalsJefferies financial groupNews ratings for regeneron pharmaceuticals dailyRegeneron pharmaceuticals profileSunbelt securities incCantor fitzgeraldRegeneron pharmaceuticalsSutton wealth advisors inc